Helminth-derived stefin-1 selectively reduces leukemic cell viability and promotes apoptosis in U937 cells
Phornthip Ploensil, Yaneenart Suwanwong, Phatchariya Phannasil, Mayuri Tarasuk, Unchalee Thonsri, Pakkawan Prapasitsin, Pongsakorn Martviset, Pathanin Chantree · 2026
Read Helminth-derived stefin-1 selectively reduces leukemic cell viability and promotes apoptosis in U937 cells by Phornthip Ploensil, Yaneenart Suwanwong, Phatchariya Phannasil, Mayuri Tarasuk, Unchalee Thonsri, Pakkawan Prapasitsin, Pongsakorn Martviset, Pathanin Chantree (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353364.txt.
Description
Ploensil and colleagues, in a 2026 laboratory study, test a protein borrowed from a parasitic flatworm against leukemia cells. The protein, called stefin-1, normally helps the worm deal with its host. Leukemia is hard to treat, in part because many drugs harm healthy cells along with cancer cells, so selective agents are prized.
The team made the worm protein and applied it to a leukemia cell line grown in dishes. Treated cancer cells died in greater numbers as dose and time rose. Normal blood cells from healthy donors, by contrast, barely changed under the same treatment. Inside the dying cells, signs pointed to the classic self-destruct program: a key execution protein was switched on, and the balance of guard proteins tipped toward death. The authors stress that this is early, dish-based work. More models and animal tests must follow before any treatment claims can be made.
Catalog record
| CREATOR | Phornthip Ploensil, Yaneenart Suwanwong, Phatchariya Phannasil, Mayuri Tarasuk, Unchalee Thonsri, Pakkawan Prapasitsin, Pongsakorn Martviset, Pathanin Chantree |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44743 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |